Correction to: Blood Cancer Journal (2015) 4, e270; doi:10.1038/bcj.2014.90; published online 2 January 2015
Since publication, the publishers have identified that this article was incorrectly placed in volume 4. The article belongs in volume 5.
The publishers would like to apologise for any inconvenience caused.
The article has been rectified and now carries the correct information.
Additional information
The online version of the original article can be found at 10.1038/bcj.2014.90
Rights and permissions
About this article
Cite this article
Patnaik, M., Wassie, E., Padron, E. et al. Erratum: Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome. Blood Cancer Journal 5, e280 (2015). https://doi.org/10.1038/bcj.2015.9
Published:
Issue Date:
DOI: https://doi.org/10.1038/bcj.2015.9
This article is cited by
-
Chronic myelomonocytic leukemia diagnosis and management
Leukemia (2021)
-
Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia
Current Hematologic Malignancy Reports (2021)
-
CMML: Clinical and molecular aspects
International Journal of Hematology (2017)
-
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis
Leukemia (2016)
-
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
Blood Cancer Journal (2016)